Bailard Inc. Makes New Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Bailard Inc. acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 402 shares of the biotechnology company’s stock, valued at approximately $239,000.

A number of other institutional investors have also recently made changes to their positions in AXON. Groupama Asset Managment bought a new stake in Axon Enterprise during the 3rd quarter valued at $200,000. Massachusetts Financial Services Co. MA bought a new position in shares of Axon Enterprise during the third quarter valued at about $120,553,000. Proficio Capital Partners LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $78,414,000. Westfield Capital Management Co. LP grew its stake in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in shares of Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after purchasing an additional 111,405 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In related news, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the sale, the insider now owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Performance

Shares of AXON opened at $534.96 on Thursday. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $40.79 billion, a P/E ratio of 138.23, a P/E/G ratio of 5.17 and a beta of 1.12. The business’s 50 day moving average price is $605.52 and its 200-day moving average price is $527.52.

Analysts Set New Price Targets

Several research firms have weighed in on AXON. The Goldman Sachs Group increased their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the stock an “overweight” rating in a report on Thursday, February 27th. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a research report on Thursday, February 20th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.